JGC
CELU icon

J. Goldman & Co’s Celularity CELU Stock Holding History

J. Goldman & Co’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,000
Closed -$1.98M – 447
2020
Q4 		$1.98M Sell
18,000
-2,000
-10% -$213K 0.1% 194
2020
Q3 		$2.1M Hold
20,000
– – 0.14% 163
2020
Q2 		$2.04M Hold
20,000
– – 0.13% 157
2020
Q1 		$1.96M Hold
20,000
– – 0.24% 106
2019
Q4 		$1.99M Hold
20,000
– – 0.14% 136
2019
Q3 		$1.99M Buy
+20,000
New +$1.96M 0.15% 156

Other funds holding CELU

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

J. Goldman & Co's CELU Position: Q1 2021 in Review

J. Goldman & Co sold out of Celularity (CELU) in Q1 2021, closing a stake of 18,000 shares — an estimated $1.98M sold.

J. Goldman & Co first reported a position in CELU in Q3 2019 and held it in 6 quarters. The position peaked at $2.1M in Q3 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

  • J. Goldman & Co reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
  • J. Goldman & Co sold 18,000 Celularity shares in Q1 2021, an estimated $1.98M.
  • J. Goldman & Co first reported a position in Celularity in Q3 2019 and held it in 6 quarters.
  • J. Goldman & Co's Celularity position peaked at $2.1M in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on J. Goldman & Co's 13F filing for Q1 2021, filed 17 May 2021.